| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 3 | 0 | 9 | 5 | 4 | 5 | 4 | 5 | 6 | 5 | 5 | 6 | 5 | 6 | 8 | 8 | 4 | 3 | 6 | 9 | 9 | 5 | 13 | 16 | 16 | 16 | 19 | 21 | 17 | 11 | 8 | 10 | 8 | 11 | 8 | 10 | 11 | 13 | 12 | 13 | 10 | 9 | 13 | 19 |
| Expenses | 3 | 0 | 7 | 4 | 4 | 4 | 3 | 4 | 4 | 5 | 4 | 5 | 4 | 5 | 6 | 6 | 5 | 5 | 6 | 6 | 14 | 5 | 7 | 8 | 11 | 10 | 12 | 14 | 14 | 9 | 8 | 9 | 9 | 8 | 8 | 9 | 10 | 10 | 9 | 10 | 10 | 11 | 10 | 14 |
| EBITDA | 1 | 0 | 2 | 1 | -1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 3 | 3 | -1 | -1 | 0 | 2 | -5 | 1 | 6 | 9 | 5 | 6 | 7 | 7 | 3 | 2 | -0 | 2 | -1 | 2 | 1 | 1 | 1 | 3 | 3 | 2 | -0 | -1 | 2 | 5 |
| Operating Profit % | 20 % | 0 % | 16 % | 19 % | -17 % | 16 % | 17 % | 17 % | 16 % | 9 % | 21 % | 21 % | 13 % | 22 % | 29 % | 32 % | -15 % | -42 % | -6 % | 23 % | -95 % | 15 % | 38 % | 53 % | 32 % | 36 % | 34 % | 32 % | -18 % | 12 % | -5 % | 15 % | -13 % | 20 % | 7 % | 10 % | 9 % | 25 % | 22 % | 17 % | -4 % | -20 % | 17 % | 27 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 0 | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | -2 | -3 | -2 | 1 | -7 | -1 | 4 | 7 | 4 | 5 | 5 | 6 | 2 | 0 | -2 | 0 | -3 | 1 | -1 | -1 | -1 | 2 | 1 | 0 | -3 | -4 | 0 | 3 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | -1 | -0 | 0 | -1 | -0 | 1 | 1 | 0 | 1 | 2 | 2 | 2 | -0 | -0 | 0 | -0 | 0 | -0 | -0 | 0 | 1 | 1 | 0 | -1 | -1 | 0 | 1 |
| Net Profit | 0 | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | -0 | 0 | 1 | 1 | -2 | -2 | -1 | 0 | -6 | -1 | 3 | 6 | 4 | 3 | 4 | 4 | 1 | 0 | -1 | 0 | -2 | 1 | -1 | -1 | -1 | 1 | 0 | 0 | -1 | -3 | 0 | 2 |
| EPS in ₹ | 0.70 | 0.00 | 1.50 | 0.25 | -1.77 | 0.16 | 0.20 | 0.24 | 0.51 | 0.03 | 0.09 | 0.12 | -0.05 | 0.26 | 0.93 | 0.52 | -0.97 | -1.37 | -0.95 | 0.26 | -3.56 | -0.37 | 1.79 | 3.74 | 2.56 | 2.17 | 2.45 | 2.80 | 0.52 | 0.25 | -0.78 | 0.04 | -1.51 | 0.33 | -0.39 | -0.31 | -0.47 | 0.66 | 0.16 | 0.03 | -0.81 | -2.03 | 0.01 | 1.52 |
Jeevan Scientific Technology
Jeevan Scientific Technology
64.50
+0.50
(0.78%)
Market Cap
127.50 Cr
PE Ratio
-61.54
Volume
6,590.00
Day High - Low
64.97 - 61.12
52W High-Low
76.99 - 32.85
There are 2 new updates from the company20 hrs ago
View
Key Fundamentals
Market Cap
127.50 Cr
EPS
-0.04
PE Ratio
-61.54
PB Ratio
2.01
Book Value
31.90
EBITDA
8.10
Dividend Yield
0.00 %
Industry
Healthcare Sector
Healthcare Technology Return on Equity
0.12
Debt to Equity
0.35
Actual
Company News
View All News
Executive Director Nageswar Rao Yarlagadda of Jeevan Scientific Technology Limited sold 1,00,000 equity shares through off-market transaction on March 27, 2026, reducing his stake from 0.67% to 0.17%.
Jeevan Scientific Gets US FDA Assessment Report
Jan 22, 2026
Jan 22, 2026Jeevan Scientific Technology Limited receives US FDA Remote Regulatory Assessment Report following review of its Hyderabad clinical pharmacology facility from October-November 2025.
Jeevan Scientific Promoters Acquire 30L WarrantsJan 07, 2026
Jan 07, 2026Multiple promoters of Jeevan Scientific Technology acquired 30,00,000 convertible warrants through preferential allotment on January 2, with Krishna Kishore Kuchipudi leading with 12,00,000 warrants.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
389.90 | #1 16,746.20 | 47.37 | #1 3,714.20 | 3.77 | #1 496 | -88.56 | 36.03 | |
434.60 | 10,886.90 | #1 24.79 | 2,946.50 | 10.53 | 407 | -6.20 | 41.53 | |
131.70 | 3,019.80 | -12.48 | 17.60 | -46.34 | -161 | -160.61 | 41.49 | |
380.70 | 1,792.80 | 29.20 | 322.30 | 0.22 | 41 | 112.87 | 33.92 | |
39.62 | 574.70 | 353.27 | 10.20 | #1 126.67 | 1 | -97.69 | 48.85 | |
64.50 | #6 127.50 | #6 -61.54 | #6 47.50 | #2 17.87 | #6 0 | #1 2,300.00 | 49.30 | |
52.70 | 122.30 | -2.99 | 806.50 | 4.78 | -56 | 20.99 | 35.92 | |
16.50 | 24.50 | 33.09 | 84.00 | 5.00 | 2 | -83.33 | 23.84 | |
15.15 | 10.60 | -0.80 | 2.10 | -78.57 | -13 | -450.00 | 39.41 |
Growth Rate
Revenue Growth
17.87 %
Net Income Growth
-107.69 %
Cash Flow Change
248.44 %
ROE
-104.40 %
ROCE
-353.70 %
EBITDA Margin (Avg.)
29.32 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 20 | 31 | 49 | 61 | 54 | 66 | 78 | 66 | 68 | 78 |
| Fixed Assets | 9 | 16 | 28 | 33 | 31 | 27 | 19 | 25 | 27 | 35 |
| Current Assets | 11 | 14 | 21 | 25 | 18 | 34 | 54 | 29 | 25 | 29 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 5 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 12 | 15 | 21 | 29 | 23 | 39 | 59 | 39 | 38 | 39 |
| Total Equity & Liabilities | 20 | 31 | 49 | 61 | 54 | 66 | 78 | 66 | 68 | 78 |
| Current Liabilities | 8 | 9 | 17 | 21 | 23 | 23 | 22 | 11 | 9 | 12 |
| Non Current Liabilities | 8 | 5 | 10 | 8 | 8 | 8 | 5 | 6 | 10 | 16 |
| Total Equity | 4 | 17 | 22 | 32 | 23 | 35 | 51 | 48 | 49 | 50 |
| Reserve & Surplus | -2 | 3 | 7 | 17 | 8 | 20 | 35 | 33 | 33 | 34 |
| Share Capital | 6 | 9 | 12 | 15 | 15 | 15 | 15 | 16 | 16 | 16 |
Cash Flow
| Cash Flow | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 1 | 2 | -2 | 4 | 24 | -23 | -6 | -0 |
| Investing Activities | -4 | -9 | -14 | -8 | -2 | -1 | -1 | -7 | -12 | -16 |
| Operating Activities | 4 | -6 | 6 | 4 | 0 | 5 | 20 | -6 | 3 | 10 |
| Financing Activities | 0 | 15 | 10 | 6 | 0 | -0 | 6 | -10 | 2 | 5 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 38.11 % | 38.11 % | 38.11 % | 38.11 % | 36.15 % | 36.47 % | 36.47 % | 36.85 % | 38.44 % | 38.48 % | 38.48 % | 38.48 % | 38.70 % | 38.70 % | 38.70 % | 37.84 % | 38.05 % | 38.05 % | 38.05 % | 38.05 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 48.08 % | 45.99 % | 46.82 % | 46.70 % | 48.56 % | 48.38 % | 44.89 % | 44.65 % | 42.87 % | 42.89 % | 45.98 % | 45.51 % | 45.50 % | 45.34 % | 45.75 % | 45.91 % | 42.99 % | 42.75 % | 42.76 % | 46.56 % |
| Others | 13.81 % | 15.90 % | 15.06 % | 15.18 % | 15.29 % | 15.15 % | 18.64 % | 18.50 % | 18.69 % | 18.63 % | 15.53 % | 16.00 % | 15.80 % | 15.96 % | 15.55 % | 16.25 % | 18.96 % | 19.21 % | 19.19 % | 15.39 % |
| No of Share Holders | 2,740 | 3,999 | 5,499 | 5,813 | 6,144 | 6,439 | 6,449 | 6,295 | 6,061 | 5,911 | 5,933 | 5,727 | 5,749 | 5,655 | 5,607 | 5,565 | 5,497 | 5,460 | 5,444 | 5,159 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.5 | 1.2 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.38 | 2.38 | 0.00 | 0.00 | 0.00 | 0.00 |
Announcements
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 201119 hrs ago
19 hrs agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 201120 hrs ago
20 hrs agoClosure of Trading Window5 days ago
5 days agoUnaudited Financial Results For The Quarter Ended 31-12-2025.Feb 11, 2026
Feb 11, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 11-02-2026Feb 11, 2026
Feb 11, 2026Closure Of The United States Food And Drug Administration (US FDA) Remote Regulatory Assessment Of JSTL And Issuance Of The Remote Regulatory Assessment Report - Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015Jan 22, 2026
Jan 22, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Jan 13, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 07, 2026
Jan 07, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 07, 2026
Jan 07, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On 02.01.2026Jan 02, 2026
Jan 02, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Dec 31, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Dec 31, 2025Update on board meetingDec 29, 2025
Dec 29, 2025Closure of Trading WindowDec 26, 2025
Dec 26, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 30-12-2025.Dec 24, 2025
Dec 24, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionDec 18, 2025
Dec 18, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationNov 12, 2025
Nov 12, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportNov 12, 2025
Nov 12, 2025Shareholder Meeting / Postal Ballot-Outcome of EGMNov 12, 2025
Nov 12, 2025Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025Nov 12, 2025
Nov 12, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 12.11.2025Nov 12, 2025
Nov 12, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12.11.2025Nov 07, 2025
Nov 07, 2025Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 About The Completion Of US FDA Remote Interactive Evaluation (RIE) Of JSTL.Nov 07, 2025
Nov 07, 2025Extra-Ordinary General Meeting Of The Company To Be Held On Wednesday 12Th Day Of November 2025 At 10.00 A.M. Through
Video Conference / Other Audio-Visual Means (VC/OAVM)Oct 18, 2025
Oct 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 15, 2025
Oct 15, 2025Announcement under Regulation 30 (LODR)-Preferential IssueOct 15, 2025
Oct 15, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 15.10.2025Oct 15, 2025
Oct 15, 2025Board Meeting Intimation for Prior Intimation Of Board Meeting For Consideration Of Fund-Raising ProposalOct 10, 2025
Oct 10, 2025Announcement under Regulation 30 (LODR)-RetirementOct 06, 2025
Oct 06, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Sep 27, 2025Outcome Of 27Th Annual General Meeting Held On 27Th September2025.Sep 27, 2025
Sep 27, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Intimation Of Book Closure And Cut-Off Date For The 27Th Annual General Meeting Of Jeevan Scientific Technology Limited.Sep 05, 2025
Sep 05, 2025Annual General Meeting Of The Company Is Scheduled To Be Held On Saturday 27Th Day Of September 2025 At 10.00 A.M Through Video Conference VC / Other Audio-Visual Means.Sep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Sep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Sep 05, 2025
Sep 05, 2025Annual General Meeting Of The Company Is Scheduled To Be Held On Saturday 27Th Day Of September 2025 At 10.00 A.M Through Video Conference "VC" I Other Audio-Visual Means.Sep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 14, 2025
Aug 14, 2025Un Audited Financial Results For The Quarter Ended 30.06.2025Aug 14, 2025
Aug 14, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.08.2025Aug 14, 2025
Aug 14, 2025Technical Indicators
RSI(14)
Neutral 48.08
ATR(14)
Volatile 3.20
STOCH(9,6)
Neutral 71.50
STOCH RSI(14)
Neutral 67.27
MACD(12,26)
Bullish 0.11
ADX(14)
Strong Trend 28.80
UO(9)
Bearish 49.94
ROC(12)
Uptrend And Accelerating 3.23
WillR(14)
Neutral -42.10
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
